Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27213096)

Published in Ann Med Health Sci Res on May 23, 2016

Authors

M O Iroezindu1, E O Ofondu2, G C Mbata2, B van Wyk3, H P Hausler4, Au Dh5, L Lynen6, P C Hopewell7

Author Affiliations

1: Infectious Diseases Unit, Department of Medicine, College of Medicine, University of Nigeria, Enugu Campus, Enugu State, Nigeria; Department of Internal Medicine, Federal Medical Centre, Owerri, Imo State, Nigeria; Faculty of Community and Health Sciences, School of Public Health, University of the Western Cape, South Africa.
2: Department of Internal Medicine, Federal Medical Centre, Owerri, Imo State, Nigeria.
3: Faculty of Community and Health Sciences, School of Public Health, University of the Western Cape, South Africa.
4: Faculty of Community and Health Sciences, School of Public Health, University of the Western Cape, South Africa; TB/HIV Care Association, Cape Town, South Africa.
5: Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA.
6: Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
7: Department of Medicine, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, USA.

Articles cited by this

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr (2003) 7.23

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS (2005) 6.83

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet (2002) 6.54

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet (2006) 5.98

Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis (2005) 5.20

An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med (2005) 3.90

Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India. BMC Infect Dis (2004) 2.64

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis (2002) 2.30

Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS (2010) 1.90

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79

Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS (2010) 1.77

Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. J Acquir Immune Defic Syndr (2011) 1.45

Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr (2011) 1.42

Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania. BMC Public Health (2008) 1.29

Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis (2008) 1.28

Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria. J Epidemiol (2009) 1.27

Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital. Pol Arch Med Wewn (2008) 1.24

Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008. PLoS One (2013) 1.02

Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria. AIDS Res Treat (2012) 1.00

Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci (2002) 0.97

Prevalence of Pulmonary Tuberculosis Among HIV Positive Patients Attending Antiretroviral Therapy Clinic. N Am J Med Sci (2013) 0.97

Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. AIDS Res Hum Retroviruses (2013) 0.94

HIV-Tuberculosis: A Study of Chest X-Ray Patterns in Relation to CD4 Count. N Am J Med Sci (2012) 0.91

Human immunodeficiency virus-associated tuberculosis: pattern and trend in the University of Ilorin Teaching Hospital. Afr J Med Med Sci (2006) 0.90

Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study. Int J Tuberc Lung Dis (2012) 0.89

Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes (2012) 0.89

Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis. AIDS Res Ther (2013) 0.85

Tuberculosis among HIV-1-infected subjects in a tertiary out-patient service in São Paulo city, Brazil. Rev Inst Med Trop Sao Paulo (2012) 0.82

Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania. Tanzan J Health Res (2011) 0.77

Prevalence of tuberculosis in HIV in Ethiopia in early HAART era: retrospective analysis. Pan Afr Med J (2013) 0.77